Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|
Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|---|---|---|---|---|---|---|---|
Q4 2024 | 48 | $1.82B | +$261M | -$240M | +$20.8M | MLTX, PRAX, JANX, ACLX, EWTX | 13F-HR | 2/14/2025, 03:01 PM |
Q3 2024 | 45 | $1.89B | +$142M | -$157M | -$15.2M | MLTX, PCVX, ACLX, LBPH, EWTX | 13F-HR | 11/14/2024, 03:11 PM |
Q2 2024 | 47 | $1.72B | +$351M | -$591M | -$240M | MLTX, CRBP, ACLX, PCVX, LBPH | 13F-HR | 8/14/2024, 03:05 PM |
Q1 2024 | 56 | $2.27B | +$569M | -$504M | +$65.1M | MLTX, EYPT, ACLX, ALPN, BBIO | 13F-HR | 5/15/2024, 03:22 PM |
Q4 2023 | 47 | $2.09B | +$534M | -$613M | -$79.5M | MLTX, AMAM, EYPT, BBIO, ACLX | 13F-HR | 2/14/2024, 03:11 PM |
Q3 2023 | 49 | $1.71B | +$290M | -$253M | +$36.4M | MLTX, BBIO, AMAM, ACLX, APLS | 13F-HR | 11/14/2023, 03:25 PM |
Q2 2023 | 61 | $1.76B | +$300M | -$426M | -$126M | MLTX, AMAM, APLS, BMEA, BBIO | 13F-HR | 8/14/2023, 03:19 PM |
Q1 2023 | 72 | $1.52B | +$319M | -$334M | -$15.4M | RXDX, MLTX, BMEA, APLS, AMAM | 13F-HR | 5/15/2023, 03:34 PM |
Q4 2022 | 72 | $1.49B | +$181M | -$213M | -$32.2M | RXDX, APLS, ACLX, MLTX, RNA | 13F-HR | 2/14/2023, 03:17 PM |
Q3 2022 | 72 | $1.42B | +$268M | -$365M | -$97.6M | RXDX, APLS, DSGN, ERAS, ACLX | 13F-HR | 11/14/2022, 03:23 PM |
Q2 2022 | 79 | $1.29B | +$253M | -$183M | +$69.7M | TPTX, DSGN, ERAS, RXDX, APLS | 13F-HR | 8/15/2022, 03:08 PM |
Q1 2022 | 77 | $1.3B | +$230M | -$126M | +$104M | TPTX, ERAS, DSGN, RXDX, GRNA | 13F-HR | 5/16/2022, 03:07 PM |
Q4 2021 | 78 | $1.68B | +$152M | -$344M | -$192M | ERAS, TPTX, DSGN, RXDX, FMTX | 13F-HR | 2/14/2022, 03:19 PM |
Q3 2021 | 88 | $2.46B | +$465M | -$348M | +$117M | ERAS, TPTX, AVIR, FMTX, RVMD | 13F-HR | 11/15/2021, 03:14 PM |
Q2 2021 | 100 | $2.56B | +$487M | -$887M | -$400M | TPTX, AVIR, FMTX, BBIO, DSGN | 13F-HR | 8/16/2021, 03:13 PM |
Q1 2021 | 115 | $3.47B | +$728M | -$419M | +$309M | AVIR, TPTX, DSGN, BBIO, FMTX | 13F-HR | 5/17/2021, 03:46 PM |
Q4 2020 | 99 | $3.44B | +$1.01B | -$450M | +$562M | TPTX, AVIR, BBIO, FMTX, OLMA | 13F-HR | 2/16/2021, 03:21 PM |
Q3 2020 | 87 | $2.27B | +$329M | -$449M | -$120M | TPTX, FMTX, RVMD, BBIO, CCXI | 13F-HR | 11/16/2020, 04:13 PM |
Q2 2020 | 77 | $2.28B | +$364M | -$413M | -$48.7M | TPTX, FMTX, CCXI, PRNB, BBIO | 13F-HR | 8/14/2020, 03:17 PM |
Q1 2020 | 68 | $1.76B | +$316M | -$285M | +$30.8M | TPTX, PRNB, BBIO, CCXI, XLRN | 13F-HR | 5/15/2020, 03:07 PM |
Q4 2019 | 61 | $2.27B | +$453M | -$307M | +$146M | TPTX, RETA, MRTX, CCXI, PRNB | 13F-HR | 2/14/2020, 03:36 PM |
Q3 2019 | 68 | $1.38B | +$168M | -$125M | +$42.4M | TPTX, MRTX, APLS, RETA, BBIO | 13F-HR | 11/14/2019, 03:10 PM |
Q2 2019 | 67 | $1.58B | +$459M | -$244M | +$215M | TPTX, MRTX, RETA, APLS, BBIO | 13F-HR | 8/14/2019, 03:17 PM |
Q1 2019 | 63 | $1.4B | +$414M | -$402M | +$11.7M | IFRX, MRTX, ASND, APLS, ANAB | 13F-HR | 5/15/2019, 03:31 PM |
Q4 2018 | 65 | $1.1B | +$159M | -$163M | -$3.57M | MRTX, ANAB, TSRO, APLS, IFRX | 13F-HR | 2/14/2019, 03:35 PM |
Q3 2018 | 60 | $1.39B | +$170M | -$190M | -$19.5M | ANAB, MRTX, NKTR, AVRO, APLS | 13F-HR | 11/14/2018, 03:15 PM |
Q2 2018 | 56 | $1.24B | +$275M | -$108M | +$168M | APLS, MRTX, ANAB, NKTR, IFRX | 13F-HR | 8/14/2018, 03:11 PM |
Q1 2018 | 49 | $1.15B | +$250M | -$121M | +$129M | NKTR, ANAB, APLS, MRTX, IFRX | 13F-HR | 5/15/2018, 03:54 PM |
Q4 2017 | 49 | $863M | +$421M | -$203M | +$218M | ANAB, NKTR, APLS, BPMC, MYOK | 13F-HR | 2/14/2018, 03:39 PM |
Q3 2017 | 51 | $566M | +$111M | -$217M | -$107M | MYOK, RXDX, OMER, ANAB, TBPH | 13F-HR | 11/14/2017, 03:17 PM |
Q2 2017 | 71 | $602M | +$112M | -$156M | -$44.1M | PTLA, TBPH, BLUE, QTNT, OMER | 13F-HR | 8/14/2017, 03:15 PM |
Q1 2017 | 75 | $689M | +$62.4M | -$154M | -$91.7M | TBPH, NVRO, PTI, GLPG, ANAB | 13F-HR | 5/15/2017, 03:23 PM |
Q4 2016 | 77 | $742M | +$99.8M | -$136M | -$36.1M | PTI, TBPH, NVRO, ALDR, EGRX | 13F-HR | 2/14/2017, 03:22 PM |
Q3 2016 | 84 | $907M | +$179M | -$150M | +$29.1M | ALDR, NVRO, TBPH, NERV, PTI | 13F-HR | 11/14/2016, 02:58 PM |
Q2 2016 | 84 | $705M | +$138M | -$123M | +$14.7M | ALDR, NVRO, HRTX, TSRO, NKTR | 13F-HR | 8/15/2016, 04:12 PM |
Q1 2016 | 84 | $664M | +$142M | -$56M | +$85.6M | ALDR, HRTX, SAGE, OMER, NKTR | Restatement | 5/17/2016, 04:50 PM |
Q4 2015 | 82 | $836M | +$139M | -$44.1M | +$94.6M | ALKS, DYAX, HRTX, EGRX, NBIX | 13F-HR | 2/16/2016, 04:11 PM |
Q3 2015 | 87 | $626M | +$87.6M | -$53.4M | +$34.2M | HRTX, ALKS, NBIX, DYAX, ARDX | 13F-HR | 11/16/2015, 04:08 PM |
Q2 2015 | 80 | $752M | +$157M | -$169M | -$12.8M | ALKS, HRTX, RCPT, ALDR, DYAX | 13F-HR | 8/14/2015, 04:22 PM |
Q1 2015 | 71 | $647M | +$102M | -$194M | -$91.2M | RCPT, ALKS, PBYI, EGRX, BMY | 13F-HR | 5/15/2015, 04:18 PM |
Q4 2014 | 70 | $649M | +$180M | -$134M | +$46.7M | RCPT, PBYI, CELG, OVAS, ALKS | 13F-HR | 2/17/2015, 04:20 PM |
Q3 2014 | 65 | $486M | +$178M | -$73.5M | +$104M | PBYI, RCPT, JAZZ, DYAX, KERX | 13F-HR | 11/14/2014, 11:21 AM |
Q2 2014 | 54 | $377M | +$139M | -$181M | -$41.8M | RCPT, OMER, QCOR, KPTI, DYAX | 13F-HR | 8/14/2014, 11:21 AM |
Q1 2014 | 46 | $435M | +$202M | -$126M | +$75.8M | MDVN, CBST, PBYI, BMRN, RCPT | 13F-HR | 5/15/2014, 11:20 AM |
Q4 2013 | 37 | $345M | $0 | $0 | MDVN, CBST, KERX, DYAX, PBYI | 13F-HR | 2/14/2014, 10:50 AM |